Markets
5.0
Roche signs major ADC licensing deal with China's Hansoh Pharma
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceCH · US · CN
Roche and Hansoh Pharmaceutical expanded their collaboration on early-stage cancer programs in a deal potentially worth over $15 billion plus royalties. This continues the trend of Western pharma tapping Chinese biotech innovation, though financial details and program specifics remain undisclosed.
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Unknown
Published 8 h ago1 sourceEvidence: Unknown
Published 8 h ago4 sourcesEvidence: Reported
Published 6 h ago5 sourcesEvidence: Reported